In support of the tumor suppressor function of TGFβR2, it has been found that in humans, reduction of or loss of TGFβR2 is associated with an increased risk of developing high-grade carcinoma in situ and invasive breast cancer [39, 40]. This evidence concerns the gene TGFBR2 and invasive breast carcinoma.